Free Trial

This company has been marked as potentially delisted and may not be actively trading.

Ariad Pharmaceuticals (ARIA) News Today

Ariad Pharmaceuticals logo

ARIA Latest News

ARIAD Stock Price History
Affimed Appoints Shawn Leland As New CEO
Terns Pharmaceuticals Finance Chief Vignola Leaving
Takeda extends lease in Kendall Square through 2040
Ariad Stock Falls On Unusually High Volume (ARIA)
Ponatinib Market Research | 2023-2030
Iclusig Market Research | 2023-2030
Ponatinib Market Research Analysis 2023-2030
Anti-Cancer Drug Market Size and Forecast till 2031
Iclusig Market Top Players and Forecast till 2031
Get Ariad Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for ARIA and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

ARIA Media Mentions By Week

ARIA Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

ARIA
News Sentiment

0.00

1.34

Average

News Sentiment

ARIA News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

ARIA Articles
This Week

0

0

ARIA Articles
Average Week

Get the Latest News and Ratings for ARIA and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Ariad Pharmaceuticals and its competitors.

Sign Up
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Related Companies and Tools


This page (NASDAQ:ARIA) was last updated on 8/29/2025 by MarketBeat.com Staff
From Our Partners